39.22

2.80% 1.07

After Hours: 39.21 -0.010 -0.03%

Liquidia Corp (LQDA)

Overview News Price History Option Chain Financials Discussions Forecast

Liquidia Corp stock is traded at $39.22, with a volume of 623.67K. It is up +2.80% in the last 24 hours and up +11.48% over the past month. Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Previous Close:

$38.15

Open:

$38.15

24h Volume:

623.67K

Relative Volume:

0.43

Market Cap:

$3.49B

Revenue:

$158.32M

Net Income/Loss:

$-68.92M

P/E Ratio:

-47.16

EPS:

-0.8317

Net Cash Flow:

$-40.02M

1W Performance:

+4.70%

1M Performance:

+11.48%

6M Performance:

+69.05%

1Y Performance:

+180.74%

1-Day Range:

$38.01

$39.45

1-Week Range:

$36.02

$39.45

52-Week Range:

$11.85

$46.67

Liquidia Corp Stock (LQDA) Company Profile

Name

Liquidia Corp

Sector

Healthcare (1105)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

919.328.4400

Address

419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC

Employee

216

Twitter

@Liquidia_Inc

Next Earnings Date

2026-05-14

Latest SEC Filings

LQDA's Discussions on Twitter

Compare LQDA vs TAK, ZTS, HLN, TEVA, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LQDA Liquidia Corp	39.22	3.35B	158.32M	-68.92M	-40.02M	-0.8317
TAK Takeda Pharmaceutical Co Adr	16.68	51.84B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	114.97	49.05B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.24	42.09B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	35.07	36.82B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	571.36	24.94B	3.18B	1.33B	1.04B	27.90

Liquidia Corp Stock (LQDA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-20-25	Initiated	Wells Fargo	Overweight
Aug-15-25	Resumed	Jefferies	Buy
May-19-25	Downgrade	Oppenheimer	Perform → Underperform
Dec-20-24	Initiated	Wells Fargo	Overweight
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Aug-19-24	Upgrade	Raymond James	Outperform → Strong Buy
Aug-16-24	Initiated	Raymond James	Outperform
Jun-25-24	Initiated	Oppenheimer	Perform
Jan-05-24	Reiterated	Needham	Buy
Sep-19-22	Resumed	Wedbush	Underperform
Sep-01-22	Downgrade	Wedbush	Neutral → Underperform
Jul-22-22	Initiated	Ladenburg Thalmann	Buy
May-31-22	Initiated	BTIG Research	Buy
May-26-22	Initiated	BofA Securities	Buy
Dec-04-20	Initiated	H.C. Wainwright	Buy
Nov-20-20	Downgrade	Wedbush	Outperform → Neutral
Nov-08-18	Resumed	Jefferies	Buy
Sep-05-18	Initiated	Wedbush	Outperform
Aug-20-18	Initiated	Jefferies	Buy
Aug-20-18	Initiated	Needham	Buy

View All

Liquidia Corp Stock (LQDA) Latest News

06:34 AM

Liquidia (LQDA) Expected to Announce Earnings on Thursday - MarketBeat

06:34 AM

Apr 29, 2026

Liquidia CAO Dana Boyle sells $59,541 in company shares By Investing.com - Investing.com UK

Apr 29, 2026

Liquidia CAO Dana Boyle sells $59,541 in company shares - Investing.com

Apr 29, 2026

Jason Adair Sells 688 Shares of Liquidia (NASDAQ:LQDA) Stock - MarketBeat

Apr 29, 2026

Insider Selling: Liquidia (NASDAQ:LQDA) CAO Sells 1,576 Shares of Stock - MarketBeat

Apr 29, 2026

Liquidia (NASDAQ: LQDA) officer sells 1,576 shares under 10b5-1 plan - Stock Titan

Apr 29, 2026

Liquidia (NASDAQ: LQDA) CBO sells 688 shares to cover RSU taxes - Stock Titan

Apr 29, 2026

Summers Value Fund (LQDA) Reports -2.7% Return in Q1 2026 - GuruFocus

Apr 29, 2026

Apr 27, 2026

Liquidia Corp (NASDAQ:LQDA): High Growth Momentum Setup Nears Breakout - ChartMill

Apr 27, 2026

Apr 24, 2026

Liquidia (NASDAQ: LQDA) touts YUTREPIA launch, cash and 2026 proxy proposals - Stock Titan

Apr 24, 2026

Liquidia Corporation Shares Surge as Growth Exceeds Market Expectations - HarianBasis.co

Apr 24, 2026